Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Martínez-Pérez
Observed names:
D. Martinez Perez,
D. Martinez-Perez,
Daniel Martinez Perez,
Daniel Martinez-Perez,
Daniel Martínez Pérez
Institutions:
Hospital Universitario La Paz,
Hospital Universitario Central de Asturias
Observed institutions:
Universidad de Oviedo,
Hospital Universitario La Paz,
Hospital La Paz Institute for Health Research,
Hospital Universitario Central de Asturias
ORCID:
0000-0002-8895-5172
Observed ORCID:
0000-0002-8895-5172
OpenAlex ID:
A5079601034
Gp-100 as a Novel Therapeutic Target in Uveal Melanoma
2021
·
Daniel Martinez-Perez
, David Viñal
, et al.
·
Cancers
·
50
PDF
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs
2024
·
Lorena Ostios-Garcia
, Daniel Martínez Pérez
, et al.
·
Cancer and Metastasis Reviews
·
48
PDF
Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience
2020
·
L. Gutierrez-Sainz
, V. Martinez-Marin
, et al.
·
Clinical & Translational Oncology
·
39
Functional proteomics of colon cancer Consensus Molecular Subtypes
2024
·
Jaime Feliu
, Angelo Gámez-Pozo
, et al.
·
British Journal of Cancer
·
15
PDF
Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospital
2025
·
Antonio Rueda-Lara
, David Viñal
, et al.
·
The Oncologist
·
12
PDF
Clinico-Pathological Features, Outcomes and Impacts of COVID-19 Pandemic on Patients with Early-Onset Colorectal Cancer: A Single-Institution Experience
2023
·
Daniel Martinez-Perez
, David Viñal
, et al.
·
Cancers
·
10
PDF
Clinicopathological characteristics and outcomes of patients with deficient mismatch repair colorectal cancer.
2022
·
David Viñal
, Daniel Martinez-Perez
, et al.
·
Journal of Clinical Oncology
·
8
A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities
2023
·
Elena López-Camacho
, Guillermo Prado-Vázquez
, et al.
·
Cancers
·
7
PDF
Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
2022
·
David Viñal
, Sergio Martinez-Recio
, et al.
·
Cancers
·
7
PDF
Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse
2025
·
Sergio Martinez-Recio
, Maria Alejandra Molina-Pérez
, et al.
·
Cancers
·
5
PDF
243P Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in metastatic breast cancer patients
2023
·
J. Álvarez Criado
, V.M. Martinez
, et al.
·
ESMO Open
·
2
PDF
Prognostic value of tumor budding in patients with stage II and III colon cancer: A single-institution experience.
2023
·
David Viñal
, Antonio Rueda-Lara
, et al.
·
Journal of Clinical Oncology
·
2
Prognostic factors in advanced pancreatic ductal adenocarcinoma patients-receiving second-line treatment: a single institution experience
2021
·
L. Gutierrez-Sainz
, D. Viñal
, et al.
·
Clinical & Translational Oncology
·
2
DPYD-guided fluoropyrimidine dose adjustment in colorectal cancer DPYD carriers: start slower to finish stronger
2025
·
Rocío Rosas-Alonso
, Nuria Rodríguez Salas
, et al.
·
Frontiers in Pharmacology
·
1
PDF
P-265 Value of the Glasgow Prognostic Score (GPS) in the prognosis of hospitalised patients with gastrointestinal cancer
2023
·
J. Peña
, A. Rueda-Lara
, et al.
·
Annals of Oncology
·
1
PDF
Impact of dose adjustment of fluoropyrimidines on toxicity in patients with DPD-deficient colorectal cancer: A single-center experience.
2023
·
Daniel Martinez-Perez
, Ismael Ghanem
, et al.
·
Journal of Clinical Oncology
·
1
Tumor microbiota, consensus molecular subtype and survival in colon adenocarcinoma.
2024
·
Nuria Rodriguez Salas
, Lucía Trilla-Fuertes
, et al.
·
Journal of Clinical Oncology
#596 One-centre based real-world data on treatment and disease evolution in BRCA germline mutated and non-mutated epithelial ovarian cancer
2023
·
Iciar Ruiz-Gutierrez
, Daniel Martinez-Perez
, et al.
·
International Journal of Gynecological Cancer
PDF
P-242 Characterisation of KRAS mutations in patients with metastatic colorectal cancer: A single institution experience
2023
·
M. Alameda
, A. Rueda-Lara
, et al.
·
Annals of Oncology
PDF
P-261 Oxaliplatine plus fluoropyrimidine versus fluoropyrimidine monotherapy as adjuvant treatment for stage III resected colorectal cancer (CRC) in older population, a single centre experience
2023
·
I. Ruiz-Gutierrez
, D. Jimenez-Bou
, et al.
·
Annals of Oncology
PDF
P-302 Survival impact of fluoropyrimidine dose adjustment in DPD deficient colorectal cancer patients: A single center experience
2023
·
D. Martinez Perez
, I. Ghanem
, et al.
·
Annals of Oncology
PDF
P-279 Adjuvant chemotherapy for patients with stage III colon cancer, three months vs six months. A single centre experience
2023
·
G. Martin-Montalvo
, D. Martinez Perez
, et al.
·
Annals of Oncology
PDF
PO-1588 Palliative care assessment in glioblastoma multiforme treated in a radiotherapy department.
2023
·
B. Deben Mendez
, M. Rodriguez Roldan
, et al.
·
Radiotherapy and Oncology
Predicting recurrence in patients with stage II and III colon cancer: Validation cohort and long-term follow-up of the experimental cohort.
2023
·
David Viñal
, Daniel Martinez-Perez
, et al.
·
Journal of Clinical Oncology
PDF
Impact of COVID-19 pandemic on diagnosis, staging, and outcomes of patients with early-onset colorectal cancer.
2023
·
Daniel Martinez-Perez
, David Viñal
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
29
Citation count:
210
H-index:
7
I10-index:
6
Year
Topic
Type